Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc.

INSPNYSE / NASDAQHealthcareSmall cap

$55.10-$1.18 (-2.1%)

Last close · Data as of Nov 20, 2026

Market cap
$1.2B
P/E
8.4x
EV / EBITDA
14.3x
Revenue
$912.0M
Net margin
15.9%
ROCE
6.3%

-33.8% over the last year

Inspire Medical Systems, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-22.8%
3M
-10.1%
6M
+24.8%
1Y
-33.8%
5Y
-79.1%

52-week range

Day change -$1.18 (-2.1%) from $56 to $55 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in INSP, bought on each weekday since 2021.

News & filings

What Inspire Medical Systems filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

StrengthOperating profit was more than a hundred times interest costs.

Concerns (1)

  • The price fell as much as 72% from a high within the last year.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA.

Read moreShow less

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Sector
Healthcare
Shares outstanding
28.6M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$1.2B
P/E
8.4x
P/B
1.6x
EV / EBITDA
14.3x
EV / Sales
1.3x
P/S
1.3x
52-week high
$143.99
52-week low
$40.05

Profitability

Operating margin
5.6%
Net margin
15.9%
EBITDA margin
8.7%
ROE
18.6%
ROCE
6.3%
ROA
16.0%
Asset turnover
1.01

Growth

Revenue
$912.0M
Revenue growth, 1Y
13.6%
Revenue CAGR, 3Y
30.8%
Net profit growth, 1Y
171.8%
Free cash flow
$78.5M

Solvency

Current ratio
6.08
Debt / Equity
0.04
Debt / Assets
0.04
CFO / Net profit
0.80
Cash / Market cap
8.6%

Where the revenue went

Of every $100 of FY2025 revenue, $16 was left as net income.

Inspire Medical Systems, Inc. income statement flow, FY2025
Inspire Medical Systems, Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$133.2M
RevenueGross profit$778.8M
Gross profitResearch and development$103.2M
Gross profitSelling, general and administrative$624.6M
Gross profitOther operating expenses$10.0k
Gross profitOperating income$51.0M
Operating incomePretax income$51.0M
Interest and other incomePretax income$14.8M
Pretax incomeNet income$65.7M
Tax benefit and otherNet income$79.7M

Revenue and net profit

Revenue grew 13.6% in FY2025; net profit is the dashed line.

Inspire Medical Systems, Inc. revenue and net profit by fiscal year
Inspire Medical Systems, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$407.9M-$44.9M
FY2023$624.8M-$21.2M
FY2024$802.8M$53.5M
FY2025$912.0M$145.4M

Cash flows

FY2025: $117.0M from operations, $78.5M free after investment (dashed).

Inspire Medical Systems, Inc. operating and free cash flow by fiscal year
Inspire Medical Systems, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$11.6M$2.5M
FY2023$24.7M$1.0M
FY2024$130.2M$91.1M
FY2025$117.0M$78.5M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$912.0M+13.6%1Y
EBITDA
$79.8M+22.7%1Y
Net profit
$145.4M+171.8%1Y
Cash from operations
$117.0M-10.2%1Y
Free cash flow
$78.5M-13.9%1Y
Revenue CAGR, 3Y
30.8%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$912.0M$79.8M$145.4M$78.5M18.6%+13.6%+171.8%

Monthly returns

Month-by-month returns of INSP across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$907.3M
Liabilities$126.2M
Equity$781.2M
Paid-in capital$927.2M
Retained earnings-$146.5M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; INSP highlighted.

P/E against peers

INSP trades at 8.4x earnings against a peer median of -10.5x.

  1. Inspire Medical Systems, Inc. (this company)8.4x

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Inspire Medical Systems, Inc.INSPthis company$1.2B8.4x1.6x18.6%14.3x
Ardent Health, Inc.ARDT$1.2B9.1x1.0x10.5%5.7x
Alphatec Holdings, Inc.ATEC$1.2B—98.1x-1154.3%—
IRADIMED CORPORATIONIRMD$1.2B53.2x12.6x23.8%41.9x
CareDx, Inc.CDNA$1.2B-55.9x3.9x-7.0%-248.1x
Kestra Medical Technologies, Ltd.KMTS$1.2B-10.5x5.8x-55.4%-10.2x
AMN Healthcare Services, Inc.AMN$1.2B—1.8x-14.9%19.3x
Schrödinger, Inc.SDGR$1.2B-11.5x3.3x-28.4%-6.6x
Wave Life Sciences Ltd.WVE$1.2B—2.3x-39.4%—
Peer median—-10.5x3.6x-21.6%-0.4x

Year-to-date ROI

INSP since 1 January, against earlier years.

Historical volatility

INSP's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Inspire Medical Systems, Inc. operating margin by fiscal year
Inspire Medical Systems, Inc. operating margin by fiscal year
DateOperating margin
FY2022-11.7%
FY2023-6.4%
FY20244.5%
FY20255.6%
LineFY2025
Cost of revenueCost Of Revenue$133.2M
Gross profitGross Profit$778.8M
Operating expensesOperating Expense$727.8M
Research and developmentResearch And Development$103.2M
Selling, general and administrativeSelling General And Administration$624.6M
Total expensesTotal Expenses$861.0M
Pretax incomePretax Income$65.7M

Learn while you research

Academy chapters picked for Inspire Medical Systems, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Value InvestingA P/E of 8.4 could be a value opportunity, or a value trap. Know the difference.7 min read
  3. 03 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  4. 04 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  5. 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  6. 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →